ProsTIC news

Our world leading research featured in the news

UroToday: The TheraP Trial video interview    

View this interview with Professor Matthew Cooperberg.  

Prostatepedia Magazine: Theranostics issue  

Visit the flipbook for this interview with Professor Michael Hofman (pages 8-11).  

3-year update from the TheraP trial 

Visit this published article in ASCO (American Society of Clinical Oncology) daily news: Lu-177 Vipivotide Tetraxetan Yields Similar OS Versus Cabazitaxel in mCRPC Progressing After Docetaxel  

Aussie researchers begin ‘world-first’ clinical trial 

Visit this article on the EVOLUTION Phase II clinical trial to evaluate the effectiveness of experimental therapy combined with immunotherapy in patients with prostate cancer.  

New technique to diagnose prostate cancer 

Visit video and article how prostate cancer experts have revealed they can improve diagnosis through sophisticated imaging techniques instead of invasive biopsies. 


Advanced Prostate Cancer Consensus Conference (APCCC)

Dr Renu Eapen presents "Best of Surgical Journals" @ ASCO GU 22 

ASCO GU22 | Imaging Biomarkers analysis from the TheraP trial 

#EANM21 - Prostate Cancer Along the Yellow Brick Road 

Plenary | Role of PSMA PET/CT for de novo vs recurrent disease 

TheraP ASCO GU presentation 

TheraP data further support LuPSMA for mCRPC 

Professor Michael Hofman talks to Nine News  

House of Wellness Program - Channel 7

Previous years